Impact of Familial Hypercholesterolemia genetic testing on high-risk cardiovascular disease patient outcomes

You are being invited to take part in a research study conducted by the AdventHealth Orlando in collaboration with Helix OpCo, LLC (“Helix”), a genetics company that performs the sequencing of DNA, and companies working with AdventHealth Orlando and Helix (such as PerkinElmer Genomics and Invitae) that provide genetic interpretation, confirmatory testing, and counseling services as part of this study. Your participation is voluntary. The genetic testing done in this research could reveal information about you that is important for your health and the health of your relatives. For people with undiagnosed FH, taking action on this information could reduce your cardiovascular risk.